[Retracted] Expression of Cysteine-Rich Secreted Acidic Protein in Multiple Myeloma and Its Effect on the Biological Behavior of Cancer Cells

Table 1

The relationship between the expression of SPARC and the clinicopathology of MM patients.

Items	N	SPARC	t/F value	value
Age (years)
≤60	35	3.05 ± 0.18	1.828	0.072
>60	42	3.13 ± 0.20
Gender
Male	43	3.08 ± 0.21	1.194	0.236
Female	34	3.02 ± 0.23
D-S staging
Phase I	12	3.06 ± 0.18	0.836	0.438
Phase II	17	3.14 ± 0.23
Phase III	48	3.07 ± 0.20
ISS staging
Phase I	13	3.04 ± 0.16	4.371	0.016
Phase II	30	3.17 ± 0.19
Phase III	34	3.25 ± 0.26
Diagnostic typing
IgG type	32	3.08 ± 0.20	0.264	0.769
IgA type	25	3.07 ± 0.19
Light chain type and others	20	3.11 ± 0.17
Lactate dehydrogenase (U/L)
<245	58	3.10 ± 0.19	0.194	0.847
≥245	19	3.09 ± 0.21
Blood calcium (mmol/L)
<2.98	61	3.11 ± 0.20
≥2.98	16	3.12 ± 0.17
Hemoglobin (g/L)
<100	50	3.30 ± 0.25	2.966	0.004
≥100	27	3.13 ± 0.22